Live feed/
Filings
/
SCHEDULE
/
0000898432-25-000189
Stake: 15.70%
Shares: 48,578,209
CUSIP: 03168L105
Class: Class A Common Stock, par value $0.01
Item 4 — Purpose of Transaction
On March 14, 2025, the Reporting Person caused TI SIE 2, LLC, a Delaware limited liability company ("TI SIE 2"), the sole member of which is a trust controlled by the Reporting Person, to sell 5,000,000 shares of Class A Common Stock in a block trade to Citigroup Global Markets Inc., at a price per share of $8.35. The purpose of this transaction was to obtain liquidity for a portion of the shares of Class A Common Stock beneficially owned by the Reporting Person.
Cross-References
Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
3 13D/G filings on this issuer
2 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 3.39
7,193,959 shares short · -33.6% vs prior
Other 13D/G Filings on Amneal Pharmaceuticals, Inc.
| Filed | Form | Filer | Stake | Shares | |
|---|
| 2025-01-23 |
SCHEDULE |
Patel Dipan |
7.70% |
23,828,992 |
view → |
| 2018-07-09 |
SC |
APHC Holdings, LLC |
— |
— |
view → |
Want this depth on every filing the moment it hits SEC EDGAR?
Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.
Request a pilot →